Hong DS - Search Results

1

Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy.

Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Curry JL, et al. Among authors: hong ds. Am J Dermatopathol. 2014 Jul;36(7):557-61. doi: 10.1097/DAD.0000000000000018. Am J Dermatopathol. 2014. PMID: 24950418

2

Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.

Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, Kurzrock R. Hong DS, et al. Arch Dermatol. 2008 Jun;144(6):779-82. doi: 10.1001/archderm.144.6.779. Arch Dermatol. 2008. PMID: 18559769

3

BRAF mutations in advanced cancers: clinical characteristics and outcomes.

El-Osta H, Falchook G, Tsimberidou A, Hong D, Naing A, Kim K, Wen S, Janku F, Kurzrock R. El-Osta H, et al. PLoS One. 2011;6(10):e25806. doi: 10.1371/journal.pone.0025806. Epub 2011 Oct 19. PLoS One. 2011. PMID: 22039425 Free PMC article.

4

Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies.

Falchook GS, Duvic M, Hong DS, Wheler J, Naing A, Lim J, Kurzrock R. Falchook GS, et al. Among authors: hong ds. Cancer Chemother Pharmacol. 2012 May;69(5):1117-26. doi: 10.1007/s00280-011-1808-4. Epub 2011 Dec 29. Cancer Chemother Pharmacol. 2012. PMID: 22205203 Free PMC article. Clinical Trial.

5

Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib.

Falchook GS, Rady P, Hymes S, Nguyen HP, Tyring SK, Prieto VG, Hong DS, Kurzrock R. Falchook GS, et al. Among authors: hong ds. JAMA Dermatol. 2013 Mar;149(3):322-6. doi: 10.1001/jamadermatol.2013.2023. JAMA Dermatol. 2013. PMID: 23552670 Free PMC article.

6

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

Henary H, Hong DS, Falchook GS, Tsimberidou A, George GC, Wen S, Wheler J, Fu S, Naing A, Piha-Paul S, Janku F, Kim KB, Hwu P, Kurzrock R. Henary H, et al. Among authors: hong ds. Ann Oncol. 2013 Aug;24(8):2158-65. doi: 10.1093/annonc/mdt115. Epub 2013 Apr 10. Ann Oncol. 2013. PMID: 23576709 Free PMC article. Clinical Trial.

7

Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions.

Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Curry JL, et al. Among authors: hong ds. Int J Dermatol. 2014 Mar;53(3):376-84. doi: 10.1111/ijd.12205. Epub 2013 Jul 24. Int J Dermatol. 2014. PMID: 23879247 Review.

8

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance.

Wheler J, Yelensky R, Falchook G, Kim KB, Hwu P, Tsimberidou AM, Stephens PJ, Hong D, Cronin MT, Kurzrock R. Wheler J, et al. BMC Cancer. 2015 Feb 18;15:61. doi: 10.1186/s12885-015-1029-z. BMC Cancer. 2015. PMID: 25886620 Free PMC article.

9

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.

Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R. Janku F, et al. Among authors: hong ds. Oncotarget. 2015 May 20;6(14):12809-21. doi: 10.18632/oncotarget.3373. Oncotarget. 2015. PMID: 25980577 Free PMC article.

10

Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.

Hong DS, Kurzrock R, Wheler JJ, Naing A, Falchook GS, Fu S, Kim KB, Davies MA, Nguyen LM, George GC, Xu L, Shumaker R, Ren M, Mink J, Bedell C, Andresen C, Sachdev P, O'Brien JP, Nemunaitis J. Hong DS, et al. Clin Cancer Res. 2015 Nov 1;21(21):4801-10. doi: 10.1158/1078-0432.CCR-14-3063. Epub 2015 Jul 13. Clin Cancer Res. 2015. PMID: 26169970 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

496 results

Search Page